Cellerant has significant expertise in hematopoietic stem cell biology ranging from basic research to process development, scale-up and assay development for commercial manufacturing. This technology has been applied to the development of several cell therapy products and Cellerant is also leveraging its expertise with normal hematopoietic stem cells to develop antibodies against malignant cells such as cancer stem cells.


Copyright ©2006-2016 Cellerant Therapeutics, Inc.